Rosmeita Chindy Nur, Budiarti Sri, Mustopa Apon Zaenal, Novianti Ela, Swasthikawati Sri, Chairunnisa Sheila, Hertati Ai, Nurfatwa Maritsa, Ekawati Nurlaili, Hasan Nurhasni
Research Center for Genetic Engineering, Research Organization for Life Sciences and Environment, National Research and Innovation Agency (BRIN), Bogor, 16911, Indonesia.
Program of Biotechnology, Graduate School, IPB University, Bogor, Indonesia.
J Genet Eng Biotechnol. 2023 Nov 20;21(1):126. doi: 10.1186/s43141-023-00571-0.
Cervical cancer caused by the human papillomavirus (HPV) is one of the most frequent malignances globally. HPV 52 is a high-risk cancer-causing genotype that has been identified as the most prevalent type in Indonesia. Virus-like particles (VLP)-based vaccinations against HPV infection could benefit from self-assembled VLP of L1 capsid protein.
The recombinant HPV 52 L1 was expressed in Pichia pastoris on a shake-flask scale with 0.5% methanol induction in this study. The copy number was used to compare the expression level and stability. The colony that survived on a solid medium containing 2000 μg/ml of Zeocin was selected and cultured to express HPV 52 L1. DNA was extracted from the chosen colony, and the copy was determined using qPCR. HPV 52 L1 protein was then purified through fast performance liquid chromatography. Transmission electron microscopy (TEM) evaluation confirmed the VLP self-assembly. The genomic DNA remained intact after 100 generations of serial cultivation under no selective pressure medium conditions, and the protein produced was relatively stable. However, the band intensity was slightly lower than in the parental colony. In terms of copy number, a low copy transformant resulted in low expression but produced a highly stable recombinant clone. Eventually, the L1 protein expressed in Pichia pastoris can self-assemble into VLP. Therefore, recombinant HPV possesses a stable clone and the ability to self-assemble into VLP.
The recombinant L1 HPV 52 protein is successfully expressed in P. pastoris within a size range of approximately 55 kDa and demonstrated favorable stability. The L1 protein expressed in Pichia pastoris successful self-assembled of HPV VLPs, thereby establishing their potential efficacy as a prophylactic vaccine.
人乳头瘤病毒(HPV)引发的宫颈癌是全球最常见的恶性肿瘤之一。HPV 52是一种高危致癌基因型,已被确定为印度尼西亚最流行的类型。基于病毒样颗粒(VLP)的HPV感染疫苗接种可能受益于L1衣壳蛋白的自组装VLP。
在本研究中,重组HPV 52 L1在毕赤酵母中通过摇瓶规模培养,以0.5%甲醇诱导表达。使用拷贝数来比较表达水平和稳定性。选择在含有2000μg/ml博来霉素的固体培养基上存活的菌落进行培养以表达HPV 52 L1。从所选菌落中提取DNA,并使用qPCR测定拷贝数。然后通过快速高效液相色谱法纯化HPV 52 L1蛋白。透射电子显微镜(TEM)评估证实了VLP的自组装。在无选择压力培养基条件下连续传代培养100代后,基因组DNA保持完整,产生的蛋白质相对稳定。然而,条带强度略低于亲代菌落。就拷贝数而言,低拷贝转化体导致低表达,但产生了高度稳定的重组克隆。最终,在毕赤酵母中表达的L1蛋白可自组装成VLP。因此,重组HPV拥有稳定的克隆以及自组装成VLP的能力。
重组L1 HPV 52蛋白在毕赤酵母中成功表达,大小约为55 kDa,表现出良好的稳定性。在毕赤酵母中表达的L1蛋白成功自组装成HPV VLP,从而确立了其作为预防性疫苗的潜在功效。